Patients with coronavirus disease 19 (COVID-19) are at high risk for thrombotic arterial and
venous occlusions. At the same time, lung histopathology often reveals fibrin-based …

Patients with COVID-19 are at high risk for thrombotic arterial and venous occlusions. Lung
histopathology often reveals fibrin-based blockages in the small blood vessels of patients …

Background Critically ill patients with coronavirus disease 2019 (COVID-19) have a
profound hypercoagulable state and often develop coagulopathy which leads to organ …

Background The significance of antiphospholipid antibodies (aPL) in COVID-19 remains
uncertain. Objectives We determined whether aPL are associated with COVID-19 and/or …

Antiphospholipid antibodies (aPL) comprise a panel of autoantibodies that reflect a potential
prothrombotic risk in several autoimmune conditions, most notably antiphospholipid …

Background Critically ill patients with coronavirus disease 2019 (COVID-19) have a
profound hypercoagulable state and often develop coagulopathy which leads to organ …

Background: COVID-19 clinical features include a hypercoagulable state that resembles the
antiphospholipid syndrome (APS), a disease characterized by thrombosis and presence of …

Abstract Background Coronavirus disease 19 (COVID‐19)–associated coagulopathy is a
hallmark of disease severity and poor prognosis. The key manifestations of this …

COVID-19 pandemic that induced by SARS-CoV-2 has been going on for more than ten
months, and shows no sign of abating. Numerous COVID-19 cohort studies have been …

Objective Patients with COVID-19 presented with an elevated prevalence of
antiphospholipid antibodies (aPL) but the relationship with thrombosis is controversial. We …